Debt-to-equity in % of Strata Critical Medical, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Strata Critical Medical, Inc. quarterly Debt-to-equity history and change rate from Q2 2020 to Q3 2025.
  • Strata Critical Medical, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 16%, a 27% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Strata Critical Medical, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 16% -6.1% -27% 30 Sep 2025
Q2 2025 17% -5.4% -24% 30 Jun 2025
Q1 2025 18% -3.9% -17% 31 Mar 2025
Q4 2024 20% -2.4% -11% 31 Dec 2024
Q3 2024 22% +1.9% +9.3% 30 Sep 2024
Q2 2024 22% +3.1% +16% 30 Jun 2024
Q1 2024 22% +6.3% +39% 31 Mar 2024
Q4 2023 22% +6.9% +45% 31 Dec 2023
Q3 2023 20% +5.9% +41% 30 Sep 2023
Q2 2023 19% +3.9% +26% 30 Jun 2023
Q1 2023 16% -0.53% -3.2% 31 Mar 2023
Q4 2022 15% -6.8% -31% 31 Dec 2022
Q3 2022 14% -18% -56% 30 Sep 2022
Q2 2022 15% -32% -68% 30 Jun 2022
Q1 2022 16% -262% -94% 31 Mar 2022
Q4 2021 22% -140% -86% 31 Dec 2021
Q3 2021 33% -98% -75% 30 Sep 2021
Q2 2021 47% -66% -59% 30 Jun 2021
Q1 2021 278% 31 Mar 2021
Q4 2020 162% 31 Dec 2020
Q3 2020 131% 30 Sep 2020
Q2 2020 112% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.